75D30125R73235 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Atlanta, GA, with responses due 2025-05-07. AwardCast estimates what this specific solicitation will close for, before you bid.
Amendment 1 is being issued to push back the due dates for Phase I and Phase II. A PDF copy of the amendment is attached as well as a Word version showing the track changes to the document. The objective of this contract is to support the Influenza Division through the testing of human sera via hema
| Winner | Award value | Offers | Date |
|---|---|---|---|
| WERFEN USA LLC | $18K | 1 | 2024-09-30 |
| ORTHO-CLINICAL DIAGNOSTICS GMBH | $4K | 2 | 2024-09-30 |
| HOLOGIC, INC. | $1.2M | n/a | 2024-09-30 |
| LUMINEX CORP | $89K | 1 | 2024-09-30 |
| PHADIA US INC | $13.8M | n/a | 2024-09-30 |
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.